Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Two siblings both had a rare case of alopecia areata at the same time.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

New treatments targeting T-cell pathways are needed for better alopecia areata management.